Rchr
J-GLOBAL ID:201801001182732685   Update date: Nov. 14, 2024

KEISHI FUJIO

藤尾 圭志 | KEISHI FUJIO
Affiliation and department:
Research field  (1): Allergies and connective tissue disease
Research theme for competitive and other funds  (14):
  • 2023 - 2026 Elucidation of immunogenetic features of childhood-onset SLE by referencing adult peripheral blood single-cell data using AI
  • 2021 - 2024 Mechanisms of pathogenic B cell differentiation associated with genetic risk for systemic lupus erythematosus.
  • 2019 - 2024 Establishment of an integrated locomotive science including dynamics of bone-articular cells and regulation by immune system
  • 2019 - 2022 Elucidation of pathogenesis of autoimmune-mediated interstitial lung disease based on epigenomic analysis
  • 2018 - 2021 Analysis of epigenetic structure responsible for inflammatory mediator production from rheumatoid arthritis synovial fibroblast
Show all
Papers (313):
  • Saeko Yamada, Bunki Natsumoto, Takayuki Sawada, Hiroaki Harada, Hirofumi Shoda, Keishi Fujio. Immune reconstitution inflammatory syndrome associated with Pneumocystis jirovecii pneumonia and otitis media in a patient with relapsing polychondritis: A case report and a review of literature. International journal of rheumatic diseases. 2024. 27. 11. e15391
  • Shinji Izuka, Natsuka Umezawa, Toshihiko Komai, Yusuke Sugimori, Naoki Kimura, Fumitaka Mizoguchi, Yuichiro Fujieda, Keita Ninagawa, Takeshi Iwasaki, Katsuya Suzuki, et al. The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions. Arthritis & rheumatology (Hoboken, N.J.). 2024
  • Haruka Tsuchiya, Mineto Ota, Haruka Takahashi, Hiroaki Hatano, Megumi Ogawa, Sotaro Nakajima, Risa Yoshihara, Tomohisa Okamura, Shuji Sumitomo, Keishi Fujio. Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis. Inflammation and regeneration. 2024. 44. 1. 29-29
  • Ayaka Iwata, Juri Maruyama, Shibata Natsuki, Akira Nishiyama, Tomohiko Tamura, Minoru Tanaka, Shigeyuki Shichino, Takao Seki, Toshihiko Komai, Tomohisa Okamura, et al. Egr2 drives the differentiation of Ly6Chi monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice. Communications biology. 2024. 7. 1. 681-681
  • Yasuhiro Tagawa, Tetsuya Saito, Hideyuki Iwai, Motohiko Sato, Seiji Noda, Akio Yamamoto, Mineto Ota, Kentaro Endo, Hideyuki Koga, Yasuhiro Takahara, et al. ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts. Immunological medicine. 2024. 1-10
more...
MISC (178):
  • 駒井俊彦, 藤尾圭志. Pathogenesis of inflammatory myopathy and single-cell profiling of patients with anti-MDA-5 antibody-positive dermatomyositis. 月刊リウマチ科. 2023. 70. 1
  • Yumi Tsuchida, Hirofumi Shoda, Tetsuji Sawada, Keishi Fujio. Role of autotaxin in systemic lupus erythematosus. Frontiers in Medicine. 2023. 10
  • 磯島 咲子, 柳井 亮, 三浦 瑶子, 羽多野 美香, 奥 健志, 金子 佳代子, 金子 祐子, 田中 良哉, 藤尾 圭志, 松下 雅和, et al. 妊娠・出産・移行医療 JCR会員アンケート研究 SLE患者の妊娠許容に対する免疫血清学的指標の影響. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2022. 66回. 438-438
  • 河野 正憲, 駒井 俊彦, 土田 優美, 土屋 遥香, 永渕 泰雄, 夏本 文輝, 神田 浩子, 庄田 宏文, 藤尾 圭志. SLEにおける疾患活動性とQOL SEL Disease Activity Score(SLE-DAS)を用いたLupus Low Disease Activity State(LLDAS)定義の試み. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2022. 66回. 366-366
  • 立石 晶子, 大野 久美子, 吉崎 歩, 柴田 彩, 浅野 善英, 佐藤 伸一, 田中 栄, 藤尾 圭志, 神田 浩子. 脊椎関節炎 乾癬性関節炎における患者自身による健康評価の検討. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2022. 66回. 397-397
more...
Awards (4):
  • 2024/06 - 日本リウマチ財団 リウマチ医学賞
  • 2023/10 - 日本免疫学会 ヒト免疫研究賞
  • 2022/04 - 日本リウマチ学会 日本リウマチ学会 学会賞
  • 2015/04 - 日本リウマチ財団 塩川美奈子・膠原病研究奨励賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page